公开(公告)号：DE69813798T2

公开(公告)日：2004-02-19

申请号：DE69813798

申请日：1998-05-22

Applicant: ABBOTT LAB

Inventor： OR SUN ,  GRIESGRABER W ,  CHU T

IPC: A61K31/70 ,  A61K31/7048 ,  A61P31/04 ,  C07H17/08

Abstract: Novel multicyclic erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formulae (I), (II), (III), (IV), (V), (VI), (VII), (VIII), (IX), (X), or (XI), pharmaceutical compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of formula (I).

公开(公告)号：DE69813798D1

公开(公告)日：2003-05-28

申请号：DE69813798

申请日：1998-05-22

Applicant: ABBOTT LAB

Inventor： OR SUN ,  GRIESGRABER W ,  CHU T

IPC: A61K31/70 ,  A61K31/7048 ,  A61P31/04 ,  C07H17/08

Abstract: Novel multicyclic erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formulae (I), (II), (III), (IV), (V), (VI), (VII), (VIII), (IX), (X), or (XI), pharmaceutical compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of formula (I).

公开(公告)号：DE69723848T2

公开(公告)日：2004-07-01

申请号：DE69723848

申请日：1997-04-25

Applicant: ABBOTT LAB

Inventor： ELLIOTT L ,  OR SUN ,  CHU T ,  GRIESGRABER W ,  PLATTNER J ,  PIREH DAISY

IPC: A61K31/04 ,  A61K31/70 ,  A61K31/7048 ,  A61K31/7052 ,  C07H17/08

Abstract: Novel 3-descladinose-2,3-anhydroerythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity selected from the group consisting of: (a) (I), (b) (II), (c) (III), and (d) (IV), pharmaceutical compositions comprising a therapeutically effective amount of a compound of formulas (I)-(IV) of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of formulas (I)-(IV) of the invention.

公开(公告)号：DE69723848D1

公开(公告)日：2003-09-04

申请号：DE69723848

申请日：1997-04-25

Applicant: ABBOTT LAB

Inventor： ELLIOTT L ,  OR SUN ,  CHU T ,  GRIESGRABER W ,  PLATTNER J ,  PIREH DAISY

IPC: A61K31/04 ,  A61K31/70 ,  A61K31/7048 ,  A61K31/7052 ,  C07H17/08

Abstract: Novel 3-descladinose-2,3-anhydroerythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity selected from the group consisting of: (a) (I), (b) (II), (c) (III), and (d) (IV), pharmaceutical compositions comprising a therapeutically effective amount of a compound of formulas (I)-(IV) of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of formulas (I)-(IV) of the invention.